Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
The American Journal of Managed Care
20h
FDA Approves Isatuximab With VRd as First-Line Option for Transplant-Ineligible Multiple Myeloma
Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...
oncnursingnews
20h
FDA Approves Isatuximab Plus VRd for Newly Diagnosed Myeloma
The FDA approved isatuximab plus bortezomib, lenalidomide, and dexamethasone for patients with newly diagnosed myeloma who ...
Targeted Oncology
21h
FDA Approves Isatuximab Plus VRd in Transplant-Ineligible Multiple Myeloma
The approval is supported by data from the phase 3 IMROZ study which demonstrated superior progression-free survival with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Released after guilty plea
Rallies in North Carolina
Sesame Place suit verdict
Lebanon: 31 dead in strike
Jurors begin deliberations
TN abortion law blocked
Russia threatens retaliation
Drug price challenge revived
$230 million crypto theft
Boeing defense chief exits
Pandas leaving for China
Feds subpoena Schaeffer
WI high court to decide
Bill to boost security OK'd
In-person voting begins
SC 1st execution in 13 years
Hand count approved in GA
FDA approves flu vaccine
Baby powder recalled
Top Hezbollah leader killed?
Sues pharmacy middlemen
144K+ Mavericks recalled
House repeals emission rules
Disney to stop using Slack
$3B for battery projects
Stein's ballot bid rejected
MS sheriff's office probe
Recalling 449K+ vehicles
1st rabies outbreak in seals
Hiker injured in bear attack
Feedback